205 related articles for article (PubMed ID: 29416606)
1. SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance.
Wang Z; Xu X; Liu N; Cheng Y; Jin W; Zhang P; Wang X; Yang H; Liu H; Tu Y
Oncotarget; 2018 Jan; 9(1):192-204. PubMed ID: 29416606
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
[TBL] [Abstract][Full Text] [Related]
3. LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis.
Li B; Zhao H; Song J; Wang F; Chen M
Hum Cell; 2020 Jan; 33(1):159-174. PubMed ID: 31713817
[TBL] [Abstract][Full Text] [Related]
4. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
[TBL] [Abstract][Full Text] [Related]
5. Role of autophagy in regulation of glioma stem cells population during therapeutic stress.
Abbas S; Singh SK; Saxena AK; Tiwari S; Sharma LK; Tiwari M
J Stem Cells Regen Med; 2020; 16(2):80-89. PubMed ID: 33414584
[TBL] [Abstract][Full Text] [Related]
6. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y
Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379
[TBL] [Abstract][Full Text] [Related]
7. Targeting the multidrug and toxin extrusion 1 gene (SLC47A1) sensitizes glioma stem cells to temozolomide.
Batara DC; Park SW; Kim HJ; Choi SY; Ohn T; Choi MC; Park SI; Kim SH
Am J Cancer Res; 2023; 13(9):4021-4038. PubMed ID: 37818053
[TBL] [Abstract][Full Text] [Related]
8. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
[TBL] [Abstract][Full Text] [Related]
9. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations.
Sugimori M; Hayakawa Y; Boman BM; Fields JZ; Awaji M; Kozano H; Tamura R; Yamamoto S; Ogata T; Yamada M; Endo S; Kurimoto M; Kuroda S
PLoS One; 2015; 10(8):e0135760. PubMed ID: 26284929
[TBL] [Abstract][Full Text] [Related]
11. The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations.
Sugimori M; Hayakawa Y; Tamura R; Kuroda S
Oncotarget; 2019 Mar; 10(24):2397-2415. PubMed ID: 31040930
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL
Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412
[TBL] [Abstract][Full Text] [Related]
13. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
[TBL] [Abstract][Full Text] [Related]
14. CCAAT/Enhancer-binding protein delta mediates glioma stem-like cell enrichment and ATP-binding cassette transporter ABCA1 activation for temozolomide resistance in glioblastoma.
Wang SM; Lin WC; Lin HY; Chen YL; Ko CY; Wang JM
Cell Death Discov; 2021 Jan; 7(1):8. PubMed ID: 33436575
[TBL] [Abstract][Full Text] [Related]
15. Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo.
Leng L; Zhong X; Sun G; Qiu W; Shi L
Tumour Biol; 2016 Oct; ():. PubMed ID: 27757851
[TBL] [Abstract][Full Text] [Related]
16. MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells.
Fukasawa K; Lyu J; Kubo T; Tanaka Y; Suzuki A; Horie T; Tomizawa A; Osumi R; Iwahashi S; Tokumura K; Murata M; Kobayashi M; Todo T; Hirao A; Hinoi E
Cancer Res Commun; 2023 Jan; 3(1):148-159. PubMed ID: 36968222
[TBL] [Abstract][Full Text] [Related]
17. Targeting Hyaluronan Interactions for Glioblastoma Stem Cell Therapy.
Hartheimer JS; Park S; Rao SS; Kim Y
Cancer Microenviron; 2019 Apr; 12(1):47-56. PubMed ID: 31079324
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme.
Sestito S; Nesi G; Daniele S; Martelli A; Digiacomo M; Borghini A; Pietra D; Calderone V; Lapucci A; Falasca M; Parrella P; Notarangelo A; Breschi MC; Macchia M; Martini C; Rapposelli S
Eur J Med Chem; 2015 Nov; 105():274-88. PubMed ID: 26498573
[TBL] [Abstract][Full Text] [Related]
19. High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PML.
Aldaz P; Martín-Martín N; Saenz-Antoñanzas A; Carrasco-Garcia E; Álvarez-Satta M; Elúa-Pinin A; Pollard SM; Lawrie CH; Moreno-Valladares M; Samprón N; Hench J; Lovell-Badge R; Carracedo A; Matheu A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562901
[TBL] [Abstract][Full Text] [Related]
20. Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma.
Liu C; Liu L; Chen X; Cheng J; Zhang H; Shen J; Shan J; Xu Y; Yang Z; Lai M; Qian C
Hepatology; 2016 Jul; 64(1):117-29. PubMed ID: 26910875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
